Haloperidol and Hyperprolactinaemia - a phase IV clinical study of FDA data
Summary:
Hyperprolactinaemia is reported as a side effect among people who take Haloperidol (haloperidol), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Olanzapine, and have Psychotic disorder.
The phase IV clinical study analyzes which people have Hyperprolactinaemia when taking Haloperidol. It is created by eHealthMe based on reports of 16,432 people who have side effects when taking Haloperidol from the FDA, and is updated regularly.
What is Haloperidol?
Haloperidol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 16,637 Haloperidol users. Check the latest studies of Haloperidol.
What is Hyperprolactinaemia?
Hyperprolactinaemia (abnormally high levels of prolactin in the blood) is found to be associated with 216 drugs and 392 conditions by eHealthMe. Check the latest studies of Hyperprolactinaemia.
16,432 people reported to have side effects when taking Haloperidol.
Among them, 176 people (1.07%) have Hyperprolactinaemia.
Among these 176 people:
How long have people been on Haloperidol when they have Hyperprolactinaemia? *
What is the gender of people who have Hyperprolactinaemia when taking Haloperidol? *
What is the age of people who have Hyperprolactinaemia when taking Haloperidol? *
What are other drugs people take besides Haloperidol? *
What are other side effects people have besides Hyperprolactinaemia? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Haloperidol and have Hyperprolactinaemia?
- Check whether Hyperprolactinaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Haloperidol:
- Haloperidol (16,637 reports)
Hyperprolactinaemia treatments and more:
- Hyperprolactinaemia (10,936 reports)
How severe was Hyperprolactinaemia and when was it recovered:
Expand to all the drugs that have ingredients of haloperidol:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Haloperidol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hyperprolactinaemia:
- Hyperprolactinaemia (216 drugs)
Browse all the conditions that are associated with Hyperprolactinaemia:
- Hyperprolactinaemia (392 conditions)
Related publications that referenced our studies
- Obayi, O., & Tagbo, N. , "Bilateral Pedal Oedema Associated with Intramuscular Haloperidol–A Rare Observation", International Neuropsychiatric Disease Journal, 2018 Jan .
- Obayi, O., & Tagbo, N. , "Bilateral Pedal Oedema Associated with Intramuscular Haloperidol–A Rare Observation", International Neuropsychiatric Disease Journal, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on haloperidol (the active ingredients of Haloperidol) and Haloperidol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Minoxidil and Isosorbide Mononitrate drug interactions for women aged 60+ - 13 seconds ago
- Hormone Replacement Therapy and Dysstasia - 22 seconds ago
- Could Excedrin cause Micturition Urgency? - 22 seconds ago
- Could Epivir cause Iron Deficiency Anaemia? - 26 seconds ago
- Trimethoprim and Azithromycin drug interactions for men aged 60+ - 31 seconds ago
- Drug interactions of Omega-3 and Miralax - 36 seconds ago
- Could Plaquenil cause Skin Hyperpigmentation? - 39 seconds ago
- Valtrex and Dapsone drug interactions for women aged 60+ - 45 seconds ago
- Serevent and Frequent Headaches for Women aged 50-59 - 47 seconds ago
- Serevent and Headaches for Women aged 50-59 - 47 seconds ago